Emerging Opportunities and Challenges: The Future of GLP-1 Receptor Agonists like Ozempic and Semaglutide in 2025
Photo By: , Source, CC GLP-1 receptor agonists such as ozempic and Semaglutide have revolutionized the management of type 2 diabetes and obesity. As we look toward 2025, the landscape…
Read More »